GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission
In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion
In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
STAT10d
GSK myeloma medicine improves survival in trial, another step in the drug’s revival
LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
FOR IMMEDIATE RELEASERelation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and ...